ResearchNet - RechercheNet

Funding Organization
Canadian Institutes of Health Research
Program Name
Operating Grant : Collaborative Health Research Projects (NSERC Partnered) ARCHIVED
(Collaborative Health Research Program (2019-2020))
Sponsor(s)

The Canadian Institutes of Health Research (CIHR) in partnership with the Natural Sciences and Engineering Research Council (NSERC).

Program Launch Date
2019-05-09
Deadline Date
TBD

Important Dates

Competition Letters of Intent (201906CPL)
CLOSED
Full Application (201910CPG)
CLOSED
Application Deadline 2019-06-25 2019-10-29
Anticipated Notice of Decision 2019-08-29 2020-04-08
Funding Start Date N/A 2020-04-01

Notices

The content of this funding opportunity has been updated
Date updated: 2019-06-04
Section(s) updated: How to Apply

A webinar session will be presented on Monday, June 3, 2019, from 1 p.m. to 2 p.m. EDT by CIHR and NSERC, to provide information on the Funding Opportunity and answer any questions from applicants. Please register using the link below. (Updated: 2019-05-29)

Webinar

CIHR will be hosting webinar(s) to support participants with the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the Webinars page.

Table of Contents

Description


The Collaborative Health Research Projects (CHRP) Initiative supports innovative, interdisciplinary, collaborative research projects, requiring participation from the natural sciences or engineering community together with the health sciences community. The initiative requires the translation of the research results to knowledge/technology users (KTUs) and related stakeholders outside the academic or training environment. As such, the proposed research projects must have a strong focus on knowledge translation (KT) and lead to health and economic benefits for Canadians through more effective health services and products and/or a strengthened health care system. KTU organizations should be meaningfully engaged throughout the research process, as appropriate, to inform research planning and design. For more information on KT at CIHR, please see About KT. Applicants are also encouraged to refer to CIHR’s Guide to Knowledge Translation Planning at CIHR: Integrated and End-of-Grant Approaches. For additional guidance regarding knowledge/technology users, please consult CHRP - Frequently Asked Questions.

Projects must include training opportunities for trainees in collaborative and interdisciplinary research of relevance to health, preparing them for employment opportunities in the private, public or not for profit sectors. Given that interactions between personnel from academic institutions and other sectors contribute to knowledge sharing and the development of trainees, CIHR and NSERC encourage secondments, cross-appointments, co-supervision of students, internships, reciprocal laboratory visits and joint workshops.

Equity, Diversity and Inclusion

Applicants are encouraged to increase the inclusion and advancement of women and other under-represented groups in the natural sciences and engineering, as one means to enhance excellence in research and training. Applicants should strive for diversity and increased gender equity when developing their group of co-applicants, collaborators and trainees. Applicants should refer to the NSERC Guide for Applicants: Considering equity, diversity and inclusion in your application for more information on integrating sex, diversity and gender equity considerations in research design, and equity and diversity among research personnel. Applicants are also encouraged to consult CIHR's reference on How to integrate sex and gender into research. CIHR expects that all research applicants will integrate gender and sex into their research designs, when appropriate.

Research Areas

Innovative interdisciplinary research projects involving collaborations between the natural sciences or engineering community together with the health sciences community, with a strong focus on knowledge translation (KT) and training leading to health and economic benefits for Canadians, more effective health services and products, and/or a strengthened health care system will be considered relevant to the overall funding opportunity.

Funds Available

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.


Top

Objectives


The Collaborative Health Research Projects (CHRP) Initiative is expected to:


Top

Eligibility


Eligibility to Apply

To be considered eligible:

*In cases where an individual could assume roles in the project as either a researcher-applicant or a representative from the KTU organization, the individual must choose the most appropriate function and may only assume one role in the application.

Note: The CIHR 'Nominated Principal Applicant' and 'Principal Applicant' roles are similar to the NSERC 'Applicant' and 'Co-applicant' roles respectively.

Eligibility of Partner(s):

The guidelines for the partnership are:

Note:  Government research laboratories, foreign research institutions, venture capitalists, technology transfer offices, or potential investors are not eligible as the principal Knowledge/Technology User. Networks of Centres of Excellence (NCE, CECR, BL-NCE, or their affiliated entities) are also not eligible. However, these entities can be included in addition to the principal KTU partner at the full application stage to broaden the impact of the Knowledge Translation plan.

*In the case of private sector organizations, this requires a Canadian-based company that carries out research and development (R&D) and/or produces goods or services within Canada, deriving the majority of its revenues from the sale of these goods or services and not from government aid. If a collaboration with a suitable Canadian-based KTU organization is not possible, justification must be provided for collaborating with a non-Canadian organization. The justification must describe how the partnership will benefit the Canadian health care system/services and what economic benefits to Canada will result from the partnership (e.g. potential to strengthen Canada’s industrial base, supply or sustain a supply chain, generate wealth, create employment and/or influence Canadian public policy). Decisions will be made on a case by case basis.

For additional guidance regarding knowledge/technology users, please consult CHRP – Frequently Asked Questions.

Applications that do not meet the eligibility criteria outlined above will be withdrawn from the competition.


Top

Guidelines


General CIHR Policies

Allowable Costs

Applicants should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for requirements regarding allowable costs and activities.

CHRP Initiative funding is targeted to academic research projects; partner KTU organizations are expected to bring their own resources to the project. Any budget items that fund the partner KTU organizations are ineligible and will not be included in the recommended budget.

Conditions of Funding


Top

Review Process and Evaluation


Relevance Review

CIHR and NSERC will perform relevance review at the LOI stage to identify applications that are in alignment with the objectives of this funding opportunity.

In addition to the above, the following criteria will also be used in conducting the relevance review:

Staff will also review the eligibility of any Principal KTU organization in cases of applicant ownership in accordance with Eligibility of Partner(s) described above.

Applications that are not deemed to be relevant will be withdrawn from the competition.

Review Process

A merit review committee, comprised of researchers and knowledge/technology user peers will evaluate letter of intents (LOIs) and full applications. The committee will be created specifically for this funding opportunity, and committee members are selected based on suggestions from many sources including the institutes, branches and partners, following the Conflict of Interest and Confidentiality Policy of the Federal Research Funding Organizations.

Due to the multidisciplinary nature of CHRP, reviews from external referees may be solicited to support the review process.

For information on CIHR’s peer review principles, see the Peer review: Overview section of CIHR’s website.

Evaluation Criteria

Evaluation Criteria – Letter of Intent (LOI)

A Merit Review committee will evaluate LOIs using the following criteria:

Upon completion of the LOI review, successful applicants will be invited to submit a full application.

Evaluation Criteria – Full Application

The Merit Review committee will evaluate full applications using the following criteria (the onus is on the applicant to address these explicitly in the proposal). Scientific merit and potential impact will be weighted equally.

Scientific Merit

  1. Quality of the research project
    • The clarity, scope and originality of research questions and objectives;
    • The appropriateness and innovativeness (where relevant) of the methods (including experimental design) and analytical frame, and the identification of, and proposed approaches to, difficulties that may be encountered;
    • Appropriate incorporation of sex as a biological variable and/or gender as a social determinant of health where applicable, including a plan to disaggregate analyses by sex and/or gender; and
    • Extent to which the budget is appropriate and justified in relation to the proposed activities.
  2. Appropriateness and interdisciplinarity of the team and management, including the team's leadership and the integration of team members
    • Appropriate expertise from both the natural sciences or engineering community and from the health sciences community to complete the research project being proposed, including complementary and interdisciplinary knowledge, expertise and experience;
    • Appropriateness of the team leadership of the project, including management, co-ordination and integration of activities; contribution and time commitment of participants; and clarity of the roles and responsibilities;
    • Experience and track record of the investigative team – importance and originality of past research, historical productivity and impact; and
    • Quality and extent of past and proposed contributions to the collaborative training of trainees in interdisciplinary research, in the health context within the proposed project (e.g., opportunity for trainees to spend time in different laboratories or settings) and to providing trainees with an understanding of the impact of the collaborative research on human health.

Potential Impact

  1. Knowledge translation and knowledge/technology user engagement
    • Impact/Potential for translation: The anticipated impact and potential for the translation of the research results into benefits for Canada, including improving the Canadian healthcare system and/or more effective Canadian health services, and economic benefits in Canada; the timeframe for the expected translation of results;
    • KT Plan: The appropriateness and potential impact of the knowledge translation plan towards clinical implementation and/or commercialization of results; evidence of a well thought out plan that includes feedback and validation steps by the KTU; the potential for Canada to benefit through the proposed KT Plan; and
    • KTU: The fit between the project objectives and the priorities of the KTU; the capacity of the KTU to exploit the research results; the degree of involvement of the KTU and their demonstrated level of engagement in the project.
  2. Training Plan
    • The extent to which all participants, including the KTU organizations are involved in the training plan;
    • The quality of the training environment and opportunity;
    • Level and content of training; and
    • The extent to which diversity and increased gender equity were considered.

In addition, the committee will consider the appropriateness and justification for the proposed budget in its final recommendations.

Funding Decision

Applications will be funded from the top down in order of ranking.

The names of successfully funded applicants will be published on the CIHR website.

Funding Partner and Internal Collaborator Participation

The opportunity to add new partners and internal collaborators to this funding opportunity may arise after publication. These partners and internal collaborators may not be listed; however, the principles that govern relevance review, including consent to share information and funding decisions, will still apply.


Top

How to Apply


Specific instructions to complete your ResearchNet application

Step 1 - Letters of Intent:

Task: Identify Participants

Task: Enter Proposal Information

Task: Complete Summary of Research Proposal

Task: Attach Other Application Materials

  1. Participating Organization Details: The following must be completed for the Principal KTU and saved in one PDF. Upload under “Other”.
    1. A signed letter of support from the Principal KTU (containing their full mailing address) is required indicating their commitment (specifying amount and whether cash or in-kind contribution).
    2. Principal Knowledge/Technology User (KTU) profile:
      Provide a concise profile (maximum 1/2 page) on only the Principal KTU, describing the nature of its operations in Canada (e.g. manufacturing, commercial activities, services provided, health care decision-making, etc.). Note that reference to a website is not acceptable in lieu of the 1/2 page KTU profile.
    3. Statement of Ownership (if applicable)
      Normally, an NPA or PA’s own company would not be eligible as a KTU. If the Principal KTU is an applicant-owned company, a Statement of Ownership attachment (maximum 1 page) must be submitted. This statement will be reviewed by program staff for eligibility. The Statement of Ownership attachment should describe the relationship between the applicant and the KTU.
      Please indicate:
      1. Applicant’s percentage ownership position in the partnering organization;
      2. Applicant’s role in the partnering organization, whether salaried or not;
      3. Applicant’s role on a governing board of the partnering organization;
      4. If the applicant is related to a person who controls, or who is a member of a governing board that controls, the partnering organization (i.e., are connected by blood relationship, marriage or common-law partnership or adoption).
  2. Participant Table (see bold headings to use, below). This table need not be final at the LOI stage but must still address all LOI eligibility requirements. Upload under the “Participant Table”.
    1. Include the names of all applicants/ team members (known to date).
      1. Clearly identify their Applicant Role (Nominated Principal Applicant, Principal Applicants, Co-Applicants, Principal Knowledge User (representative of the Principal KTU organization), Knowledge Users or Collaborators)
      2. Position or title
      3. Organization/Affiliation
      4. Field of Expertise (Natural Sciences and Engineering, Health, other). Must be complete in order to confirm eligibility requirements.
  3. Certificates of Completion for the sex- and gender-based analysis training modules for all Principal Applicants (including the Nominated Principal Applicant). Upload all under “Other” as 1 PDF.
    • After completing the appropriate training module that applies to the research project, you will receive a Certificate of Completion that you will save and upload here. The training module should take approximately 40 minutes to complete.
    • N.B. The certificate is issued as a secured document; however, you must upload a copy of the certificate (e.g. print screen) as an unsecured PDF file in order to successfully append the document. Scan documents and photocopies are acceptable.

Note: Additional KTU organizations may be added at the full application stage; however, the principal KTU organization identified within the LOI cannot be substituted.

Task: Peer Review Administration

Task: Print/Upload Signature Pages

Step 2 – Full Application:

Submission Requirements

This funding opportunity follows the eApproval process. This means that when the applicant submits the application, it will be directed electronically to the Research Institution which the applicant has identified as the Institution Paid. The Research Institution will review the application and submit their approval electronically to CIHR on behalf of the applicant.

Specific instructions to complete your ResearchNet application

Task: Identify Participants

Task: Enter Proposal Information

Task: Complete Summary of Research Proposal

Task: Enter Budget information

Task: Attach Other Application Materials

Task: Download Supplemental Application Information

Task: Peer Review Administration

Task: Print/Upload Signature Pages


Top

Contact Information


For all inquiries, please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
Email: support-soutien@cihr-irsc.gc.ca

For service hours, please consult our Contact us page.


Top

Sponsor Description


Note: Additional funding partners/internal collaborators, including from industry and the private sector, may join this funding initiative over the coming year.

Partners

Natural Sciences and Engineering Research Council (NSERC)
NSERC is Canada's largest federal funding council in the natural sciences and engineering. NSERC will help make Canada a country of discoverers and innovators for the benefit of all Canadians. It will reach this vision by investing in people, discovery and innovation through programs that support university research in the natural sciences and engineering on the basis of national competitions.

Internal Collaborators

Canadian Institutes of Health Research
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada’s health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.


Top

Additional Information


Clinical Trials will NOT be funded through this Funding Opportunity. However, the use of randomization in basic biomedical research studies is accepted.


Top

Date Modified: